查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1888665

免疫組庫定序市場規模、佔有率和趨勢分析報告：按產品/服務、類型、應用、最終用途、地區和細分市場預測（2025-2033 年）

Immune Repertoire Sequencing Market Size, Share & Trends Analysis Report By Product & Service, By Type, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

免疫組庫定序市場摘要

2024 年全球免疫組庫定序市場規模估計為 3.282 億美元，預計到 2033 年將達到 8.942 億美元。

預計從 2025 年到 2033 年，該市場將以 11.89% 的複合年成長率成長。市場成長的促進因素包括次世代定序技術的日益普及、其在免疫療法和疫苗開發中的應用，以及對精準醫療研究的投資。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 免疫組庫定序市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 免疫組庫定序市場分析工具
    • 產業分析 - 波特五力
    • PESTEL 分析

第4章 免疫組庫定序市場：按產品和服務分類的估算和趨勢分析

  • 全球免疫組庫定序市場：按產品和服務分類的差異分析
  • 全球免疫組庫定序市場規模及趨勢分析（依產品及服務分類，2021-2033年）
  • 裝置
  • 檢測試劑盒和試劑
    • TCR套件
    • BCR試劑盒
    • 其他
  • 服務

第5章 免疫組庫定序市場：按類型分類的估算與趨勢分析

  • 全球免疫組庫定序市場：按類型分類的差異分析
  • 全球免疫組庫定序市場規模及趨勢分析（按類型分類，2021-2033年）
  • 批量免疫組庫測序
  • 單細胞免疫組庫定序

第6章：免疫組庫定序市場：按應用分類的估算與趨勢分析

  • 全球免疫組庫定序市場：按應用領域分類的差異分析
  • 全球免疫組庫定序市場規模及應用趨勢分析（2021-2033年）
  • 腫瘤學和癌症免疫療法
  • 自體免疫疾病/發炎性疾病
  • 感染疾病與疫苗研發
  • 移植與免疫耐受
  • 其他

第7章 免疫組庫定序市場：依最終用途分類的估算與趨勢分析

  • 全球免疫組庫定序市場：依最終用途分類的差異分析
  • 全球免疫組庫定序市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 學術和研究機構
  • 製藥和生物技術公司
  • 其他

第8章：免疫組庫定序市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 2024年商業市場分析
  • 公司簡介/列表
    • QIAGEN
    • New England Biolabs
    • Takara Bio
    • Illumina, Inc.
    • iRepertoire
    • BGI
    • Danaher
    • Creative Biolabs
    • Nucleus Biotech
    • Celemics, Inc.
Product Code: GVR-4-68040-819-4

Immune Repertoire Sequencing Market Summary

The global immune repertoire sequencing market size was estimated at USD 328.2 million in 2024 and is projected to reach USD 894.2 million by 2033, growing at a CAGR of 11.89% from 2025 to 2033. The increasing adoption of next-generation sequencing technologies, applications in immunotherapy and vaccine development, and investments in precision medicine research drive the market growth.

Global Immune Repertoire Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global immune repertoire sequencing market report based on product & service, type, application, end-use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Assay Kits & Reagents
    • TCR kits
    • BCR kits
    • Others
  • Services
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Bulk immune repertoire sequencing
  • Single cell immune repertoire sequencing
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology & Cancer Immunotherapy
  • Autoimmune & Inflammatory Diseases
  • Infectious Diseases & Vaccine Development
  • Transplantation & Immune Tolerance
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Immune Repertoire Sequencing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing adoption of personalized medicine
      • 3.2.1.2. Rising prevalence of immune-related diseases
      • 3.2.1.3. Advancements in high-throughput sequencing technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of sequencing technologies
      • 3.2.2.2. Complex data analysis and interpretation
  • 3.3. Immune Repertoire Sequencing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Immune Repertoire Sequencing Market: Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Immune Repertoire Sequencing Market Product & Service Movement Analysis
  • 4.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Assay Kits & Reagents
    • 4.5.1. Assay Kits & Reagents market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2. TCR kits
      • 4.5.2.1. TCR kits market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3. BCR kits
      • 4.5.3.1. BCR kits market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Immune Repertoire Sequencing Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Immune Repertoire Sequencing Market Type Movement Analysis
  • 5.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Bulk immune-repertoire sequencing
    • 5.4.1. Bulk immune-repertoire sequencing market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Single-cell immune-repertoire sequencing
    • 5.5.1. Single-cell immune-repertoire sequencing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Immune Repertoire Sequencing Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Immune Repertoire Sequencing Market Application Movement Analysis
  • 6.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Oncology & Cancer Immunotherapy
    • 6.4.1. Oncology & Cancer Immunotherapy market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Autoimmune & Inflammatory Diseases
    • 6.5.1. Autoimmune & Inflammatory Diseases market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Infectious Diseases & Vaccine Development
    • 6.6.1. Infectious Diseases & Vaccine Development market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Transplantation & Immune Tolerance
    • 6.7.1. Transplantation & Immune Tolerance market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Immune Repertoire Sequencing Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Immune Repertoire Sequencing Market End Use Movement Analysis
  • 7.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Pharmaceutical & Biotechnology Companies
    • 7.5.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Immune Repertoire Sequencing Market: Regional Estimates & Trend Analysis by Product & Service, Type, Application, and End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Regulatory framework
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. QIAGEN
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. New England Biolabs
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Takara Bio
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Illumina, Inc.
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. iRepertoire
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. BGI
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Danaher
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Creative Biolabs
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Nucleus Biotech
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Celemics, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Immune repertoire sequencing market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 5 Global Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America Immune repertoire sequencing market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 9 North America Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 10 North America Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 11 North America Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 13 U.S. Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 14 U.S. Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 15 U.S. Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 17 Canada Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 18 Canada Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 19 Canada Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Mexico Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 22 Mexico Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 23 Mexico Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe Immune repertoire sequencing market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 26 Europe Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 27 Europe Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 28 Europe Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Germany Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 30 Germany Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 31 Germany Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 32 Germany Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 33 UK Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 34 UK Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 35 UK Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 36 UK Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 38 France Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 39 France Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 40 France Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Italy Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 43 Italy Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 44 Italy Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 46 Spain Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 47 Spain Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 48 Spain Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 50 Denmark Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 51 Denmark Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 52 Denmark Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 54 Sweden Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 55 Sweden Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 58 Norway Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 59 Norway Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 60 Norway Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Immune repertoire sequencing market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 66 China Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 67 China Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 68 China Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 69 China Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Japan Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 71 Japan Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 72 Japan Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 73 Japan Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 75 India Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 76 India Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 77 India Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 78 South Korea Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 79 South Korea Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 80 South Korea Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Korea Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Australia Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 83 Australia Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 84 Australia Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 85 Australia Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 87 Thailand Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 88 Thailand Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 89 Thailand Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Immune repertoire sequencing market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 92 Latin America Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 93 Latin America Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Latin America Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 95 Brazil Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 96 Brazil Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 97 Brazil Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 100 Argentina Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 101 Argentina Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 102 Argentina Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 103 MEA Immune repertoire sequencing market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 105 MEA Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 106 MEA Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 107 MEA Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 108 South Africa Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 109 South Africa Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 110 South Africa Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 111 South Africa Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 116 UAE Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 117 UAE Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 118 UAE Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 119 UAE Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Immune repertoire sequencing market, by product & service, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Immune repertoire sequencing market, by type, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Immune repertoire sequencing market, by application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Immune repertoire sequencing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Immune health supplements market: Market outlook
  • Fig. 5 Immune health supplements market: Segment outlook
  • Fig. 6 Immune health supplements market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Immune health supplements market driver impact
  • Fig. 9 Immune health supplements market restraint impact
  • Fig. 10 Immune health supplements market: Product & Service outlook and key takeaways
  • Fig. 11 Immune health supplements market: Product & Service movement analysis
  • Fig. 12 Instruments, 2021 - 2033 (USD Million)
  • Fig. 13 Assay Kits & Reagents, 2021 - 2033 (USD Million)
  • Fig. 14 TCR kits, 2021 - 2033 (USD Million)
  • Fig. 15 BCR kits, 2021 - 2033 (USD Million)
  • Fig. 16 Others, 2021 - 2033 (USD Million)
  • Fig. 17 Services, 2021 - 2033 (USD Million)
  • Fig. 18 Immune health supplements market: Type outlook and key takeaways
  • Fig. 19 Immune health supplements market: Type movement analysis
  • Fig. 20 Bulk immune-repertoire sequencing, 2021 - 2033 (USD Million)
  • Fig. 21 Single-cell immune-repertoire sequencing, 2021 - 2033 (USD Million)
  • Fig. 22 Immune health supplements market: Application outlook and key takeaways
  • Fig. 23 Immune health supplements market: Application movement analysis
  • Fig. 24 Oncology & Cancer Immunotherapy, 2021 - 2033 (USD Million)
  • Fig. 25 Autoimmune & Inflammatory Diseases, 2021 - 2033 (USD Million)
  • Fig. 26 Infectious Diseases & Vaccine Development, 2021 - 2033 (USD Million)
  • Fig. 27 Transplantation & Immune Tolerance, 2021 - 2033 (USD Million)
  • Fig. 28 Others, 2021 - 2033 (USD Million)
  • Fig. 29 Immune health supplements market: End use outlook and key takeaways
  • Fig. 30 Immune health supplements market: End use movement analysis
  • Fig. 31 Academic & Research Institutes, 2021 - 2033 (USD Million)
  • Fig. 32 Pharmaceutical & Biotechnology Companies, 2021 - 2033 (USD Million)
  • Fig. 33 Others, 2021 - 2033 (USD Million)
  • Fig. 34 Global Immune repertoire sequencing market: Regional outlook and key takeaways
  • Fig. 35 Global Immune repertoire sequencing market: Regional movement analysis
  • Fig. 36 North America Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Canada Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 UK Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Germany Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 France Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Spain Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Norway Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 China Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 India Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Australia Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Middle East and Africa Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait Immune repertoire sequencing market estimates and forecasts, 2021 - 2033 (USD Million)